Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program (SMWII)

January 13, 2026 updated by: Matthew P Buman, PhD, Arizona State University
This is a 2-arm group-randomized hybrid effectiveness-implementation (HEI type 2) study to test an evidence-based intervention (EBI) known as Stand & Move at Work(SMW) to reduce sedentary time in the workplace, and to test the role of expert facilitation (SMW+) for improving intervention fidelity.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Primary Aim: To assess worksite-level reduction in sedentary time and intervention fidelity over 12 months Secondary Aim: To assess cost effectiveness of the intervention at 12 and 24 months

Study Type

Interventional

Enrollment (Estimated)

4800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Matthew Buman, PhD
  • Phone Number: 602-496-8617
  • Email: mbuman@asu.edu

Study Contact Backup

Study Locations

  • United States
    • Arizona
      • Phoenix, Arizona, United States, 85004
        • Recruiting
        • Arizona State University College of Health Solutions
        • Contact:
        • Principal Investigator:
          • Matthew Buman, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Worksite-Level Inclusion Criteria:

  • More than 80% of employees work full time (30+ hours per week).
  • At least 45 employees in the worksite with sit-stand workstations working at least three days per week
  • Occupations require primarily desk-based work (e.g., computer- and telephone-based)
  • Willing to allow the researchers to distribute online research surveys to all employees in order to allow the program to be evaluated.
  • Allow 30 randomly selected individuals to wear an activity monitor in several 7-day intervals across two years.
  • Willing to be randomized to either intervention.
  • Willing to identify one or more worksite champions to implement the Stand & Move at Work™ program.

Worksite-level exclusion criteria:

  • Involved in previous interventions to reduce sitting and increase standing and moving at work in the last 24 months.
  • Involved in the Stand and Move I intervention.
  • Another worksite within the same organization is participating in the program and contamination across those worksites cannot be avoided.

Employee-level inclusion criteria:

  • 18 years or older
  • Willing to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Stand & Move at Work
Given an evidence-based workplace program to reduce sedentary behavior and increase standing and moving using a web-based platform. The web platform has a toolkit with strategies and guides for the worksite Champions to address changes at the environmental, social, and cultural levels.
Behavioral: Stand & Move at Work
Web-based platform only.
Other Names:
  • SMW
Experimental: Stand & Move at Work+
This arm will receive access to the same web-based platform and toolkit as the other arm. Additionally, worksites in this arm will be assigned and expert facilitator who will meet regularly with the worksite Champions to assist with implementation.
Behavioral: Stand & Move at Work+
Web-based platform and support from an expert facilitator
Other Names:
  • SMW+

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in posture
Time Frame: Baseline, 3 month, 12 months, and 24 months
Accelerometer-based (activPAL) sensor fixed to the thigh that measures sitting, standing, and lying down over 7 days.
Baseline, 3 month, 12 months, and 24 months
Competence/Adherence
Time Frame: 3 months
A questionnaire-based assessment of intervention fidelity completed by study champions (competence and adherence) through an online portal. Based on Likert-scales and interval scales. SCORING RANGE
3 months
Competence/Adherence
Time Frame: 12 months
A questionnaire-based assessment of intervention fidelity completed by study champions (competence and adherence) through an online portal. Based on Likert-scales and interval scales. SCORING RANGE
12 months
Competence/Adherence
Time Frame: 24 months
A questionnaire-based assessment of intervention fidelity completed by study champions (competence and adherence) through an online portal. Based on Likert-scales and interval scales. SCORING RANGE
24 months
Intervention Fidelity
Time Frame: 3 months
A questionnaire-based assessment of intervention fidelity completed by study participants regarding the advocates (competence and adherence) through an online portal. SCORING RANGE
3 months
Intervention Fidelity
Time Frame: 12 months
A questionnaire-based assessment of intervention fidelity completed by study participants regarding the advocates (competence and adherence) through an online portal. SCORING RANGE
12 months
Intervention Fidelity
Time Frame: 24 months
A questionnaire-based assessment of intervention fidelity completed by study participants regarding the advocates (competence and adherence) through an online portal. SCORING RANGE
24 months
Researcher derived measures of fidelity
Time Frame: 3 months
A single composite measure of directly-observed intervention delivery assessed via web analytics, participation rates, and other calculated measures of fidelity.
3 months
Researcher derived measures of fidelity
Time Frame: 12 months
A single composite measure of directly-observed intervention delivery assessed via web analytics, participation rates, and other calculated measures of fidelity.
12 months
Researcher derived measures of fidelity
Time Frame: 24 months
A single composite measure of directly-observed intervention delivery assessed via web analytics, participation rates, and other calculated measures of fidelity.
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of program-related costs
Time Frame: Baseline, 3 month, 12 months, and 24 months.
Program-related costs above and beyond cost of sit-stand workstation which may include advocate time spent implementing the intervention and intervention supplies.
Baseline, 3 month, 12 months, and 24 months.
Change in health-related quality of life
Time Frame: Baseline, 3 month, 12 months, and 24 months.
36-Item Short Form Survey (SF36) assesses quality of life that will be used to estimate incremental cost effectiveness. Scored from 0 to 100, with 0 being maximum disability and 100 being no disability.
Baseline, 3 month, 12 months, and 24 months.
Change in musculoskeletal pain
Time Frame: Baseline, 3 months, 12 months, and 24 months.
The Nordic Musculoskeletal Questionnaire (NMQ) assesses pain by bodily region on a Likert-type scale SCORING RANGE.
Baseline, 3 months, 12 months, and 24 months.
Change in Work Productivity and Activity Impairment Questionnaire - General Health
Time Frame: Baseline, 3 months, 12 months, and 24 months.
Work Productivity and Activity Impairment Questionnaire: General Health (WPAI:GH) assesses impairment in paid work and activities in the preceding 7 days on an interval and Likert-type scale with a higher score indicating greater impariment.
Baseline, 3 months, 12 months, and 24 months.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in sedentary behavior
Time Frame: Baseline, 3 month, 12 months, and 24 months.
Sedentary behavior questionnaire (SBQ) is a brief questionnaire to assess time spent sitting in different work and non-work contexts SCORING RANGE
Baseline, 3 month, 12 months, and 24 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Arizona State University

Collaborators

National Cancer Institute (NCI)
University of Minnesota
University of Utah
University of Virginia
University of Nebraska
The University of Queensland

Investigators

  • Principal Investigator: Matthew Buman, PhD, Arizona State University College of Health Solutions
  • Principal Investigator: Mark Pereira, PhD, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2022

Primary Completion (Estimated)

February 28, 2026

Study Completion (Estimated)

February 28, 2027

Study Registration Dates

First Submitted

December 1, 2021

First Submitted That Met QC Criteria

July 29, 2022

First Posted (Actual)

August 3, 2022

Study Record Updates

Last Update Posted (Estimated)

January 14, 2026

Last Update Submitted That Met QC Criteria

January 13, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1R01CA250527 (U.S. NIH Grant/Contract)
  • 1R01CA250527-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Access to databases and associated software tools generated under the project will be available for educational, research and non-profit purposes. Such access will be provided using web-based applications, as appropriate. Publication of data shall occur during the project, if appropriate, and at the end of the project, consistent with normal scientific practices. Research data to document, support and validate research findings will be made available after the main findings from the final research data set have been accepted for publication. Such research data will be de-identified to prevent the disclosure of personal identifiers.

IPD Sharing Time Frame

Protocol and analysis plan will be available for sharing in 2022. Analytical code and data sets will be available for sharing following publication of the primary and secondary outcome papers.

IPD Sharing Access Criteria

Public access via request to the study Principal Investigators

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sedentary Behavior

Clinical Trials on Stand & Move at Work

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe